This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia
BMC Cancer Open Access 22 October 2018
-
A plasmonic colorimetric strategy for visual miRNA detection based on hybridization chain reaction
Scientific Reports Open Access 18 August 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Löwenberg B . Acute myeloid leukemia: the challenge of capturing disease variety. Hematology Am Soc Hematol Educ Program 2008; 2008: 1–11.
Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, van Galen P et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 2011; 17: 1086–1093.
Bartel DP . Micrornas: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297.
Chen C-Z, Li L, Lodish HF, Bartel DP . Micrornas modulate hematopoietic lineage differentiation. Science 2004; 303: 83–86.
Gocek E, Wang X, Liu X, Liu C-G, Studzinski GP . Microrna-32 upregulation by 1,25-dihydroxyvitamin d3 in human myeloid leukemia cells leads to bim targeting and inhibition of arac-induced apoptosis. Cancer Res 2011; 71: 6230–6239.
Han YC, Park CY, Bhagat G, Zhang J, Wang Y, Fan JB et al. Microrna-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 2010; 207: 475–489.
Bousquet M, Harris MH, Zhou B, Lodish HF . Microrna mir-125b causes leukemia. Proc Natl Acad Sci USA 2010; 107: 21558–21563.
O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J et al. Sustained expression of microrna-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008; 205: 585–594.
Marcucci G, Maharry KS, Metzeler KH, Volinia S, Wu YZ, Mrózek K et al. Clinical role of micrornas in cytogenetically normal acute myeloid leukemia: mir-155 upregulation independently identifies high-risk patients. J Clin Oncol 2013; 31: 2086–2093.
de Leeuw DC, Denkers F, Olthof MC, Rutten AP, Pouwels W, Schuurhuis GJ et al. Attenuation of microrna-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication. Cancer Res 2014; 74: 2094–2105.
Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368: 2059–2074.
Feller N, van der Pol MA, van Stijn A, Weijers GW, Westra AH, Evertse BW et al. MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia. Leukemia 2004; 18: 1380–1390.
Terwijn M, van Putten WL, Kelder A, van der Velden VH, Brooimans RA, Pabst T et al. High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the hovon/sakk aml 42a study. J Clin Oncol 2013; 31: 3889–3897.
Silva FP, Swagemakers SM, Erpelinck-Verschueren C, Wouters BJ, Delwel R, Vrieling H et al. Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by runx1 mutation status. Blood 2009; 114: 3001–3007.
Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 2014; 506: 328–333.
Xu X, Wells A, Padilla MT, Kato K, Kim KC, Lin Y . A signaling pathway consisting of miR-551b, catalase and MUC1 contributes to acquired apoptosis resistance and chemoresistance. Carcinogenesis 2014; 35: 2457–2466.
Acknowledgements
Part of this research was financed by a grant (08-0075) from World Wide Cancer Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
de Leeuw, D., Verhagen, H., Denkers, F. et al. MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia. Leukemia 30, 742–746 (2016). https://doi.org/10.1038/leu.2015.160
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2015.160
This article is cited by
-
NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia
BMC Cancer (2018)
-
MicroRNAs as prognostic biomarker and relapse indicator in leukemia
Clinical and Translational Oncology (2017)
-
A plasmonic colorimetric strategy for visual miRNA detection based on hybridization chain reaction
Scientific Reports (2016)